Nanovibronix (NAOV) Competitors

Nanovibronix (NASDAQ:NAOV) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Do analysts recommend NAOV or AMIX?

Autonomix Medical has a consensus price target of $16.50, indicating a potential upside of 1,533.66%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Autonomix Medical is more favorable than Nanovibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Autonomix Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders hold more shares of NAOV or AMIX?

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 6.3% of Nanovibronix shares are held by company insiders. Comparatively, 32.4% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has stronger earnings & valuation, NAOV or AMIX?

Nanovibronix has higher revenue and earnings than Autonomix Medical. Nanovibronix is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.56M	0.55	-$3.70M	-$13.53	-0.40
Autonomix Medical	N/A	N/A	-$11.41M	-$5.74	-0.18

Does the media refer more to NAOV or AMIX?

In the previous week, Autonomix Medical had 5 more articles in the media than Nanovibronix. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Nanovibronix. Autonomix Medical's average media sentiment score of 0.72 beat Nanovibronix's score of -0.65 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Nanovibronix	Negative
Autonomix Medical	Positive

Which has more volatility and risk, NAOV or AMIX?

Nanovibronix has a beta of 1.83, meaning that its stock price is 83% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -2.96, meaning that its stock price is 396% less volatile than the S&P 500.

Is NAOV or AMIX more profitable?

Autonomix Medical has a net margin of 0.00% compared to Nanovibronix's net margin of -380.29%. Nanovibronix's return on equity of -45.24% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-380.29%	-45.24%	-34.24%
Autonomix Medical	N/A	-172.93%	-133.39%

Summary

Autonomix Medical beats Nanovibronix on 9 of the 15 factors compared between the two stocks.